About PSM
Partnership for Safe Medicines Site Map
SITE MAP About Partnership for Safe Medicines Members Board of Directors Press Releases Contact Us Counterfeit Drugs: Stay Informed News Archives Alerts & Drug Warnings Safe Options for Buying Rx Drugs VIPPS Program Save Savings Protecting Yourself & Your Family SAFEDRUG SafeMeds Alert System 10 Ways you can fight counterfeit drugs Become An Expert Need…
[...]Partnership for Safe Medicines Arms Public Against Counterfeit Drugs
Consumer protection group's new resource helps Americans cut prescription costs without compromising drug safety.
WASHINGTON – A collection of online educational materials are now available for free to consumers to help fend off the dangers of contaminated or counterfeit drugs. Unveiled today by the Partnership for Safe Medicines, Consumer Resources is designed to help consumers ensure the safety of their prescription drugs and includes guides on safely purchasing medicines online and how to save money without compromising drug safety.
[...]About The Partnership For Safe Medicines
About Partnership For Safe Medicines Counterfeit drugs are a serious patient safety problem. The Partnership for Safe Medicines is working together to protect the safety of your prescription drugs. Download our organizational profile book. [PDF] The Partnership for Safe Medicines is a group of not-for-profit organizations and individuals that have policies, procedures, or programs to…
[...]Counterfeit Drugs and Baby Formula
Four infants are dead and more than 54,000 children in China have suffered from kidney stones and kidney failure this past year as a result of baby formula and powdered milk tainted with melamine, an industrial chemical used to make plastics, glue and is found in pesticides. The toxin found its way into the milk products from more than 30 Chinese companies because of its ability to make the milk appear high in protein.
[...]Politics and Counterfeit Drugs
Currently, the United States has one of the safest drug supplies in the world because its pharmaceutical supply system is “closed” to importation. Once a drug is outside the strictly regulated distribution channel, there is no guarantee of its authenticity, effectiveness, or safety. We know from the recent incident in China of the deliberately contaminated…
[...]Consumer Protection Group Supports West African Anti-Counterfeit Drug Efforts
Partnership for Safe Medicines shares expertise with leaders to combat contraband and counterfeit drugs.
ACCRA, Ghana (Sept. 9, 2008) – To combat the increasing amounts of contraband and counterfeit drugs threatening public health, West African government officials, business leaders, and non-profit organizations gathered today for the Stakeholder Forum on Safe Medicines in Accra, Ghana. The Partnership for Safe Medicines, a coalition of organizations and individuals dedicated to protecting consumers from counterfeit medicines, helped lead a discussion about how the region can work together to address this important health problem.
[...]Thomas T. Kubic
Thomas T. Kubic is the President and CEO of the Pharmaceutical Security Institute (PSI), a non-profit association dedicated to protecting the public health by insuring the distribution of pharmaceuticals that are safe and effective. Mr. Kubic previously served on the World Health Organization’s IMPACT Enforcement Working Group. With the 2013 launch of the Pharmaceutical Industry Initiative to Combat Crime (PIICC), he participated in the Technical Committee to assist Interpol’s global efforts to address pharmaceutical crime. He is an industry advisor to the Permanent Forum Against International Pharmaceutical Counterfeiting. Additionally, he has provided testimony before senior government officials around the world concerning the international nature of counterfeiting and its devastating impact. He is a Director and the Treasurer for the Partnership for Safe Medicines.
Partnership for Safe Medicines Issues Statements on Series of Drug Safety Hearings
Recently, the heparin contamination and drug safety in general have taken center stage on Capitol Hill. In the past two weeks, there has been three hearings in the House and one in the Senate examining issues affecting the safety of our prescription medicines.
[...]Heparin Update: 62 Suspected U.S. Fatalities, 2 Upcoming Hearings
The heparin fallout continues. As an update to our March 13 post, the Food and Drug Administration (FDA) now reports 62, not 19, suspicious deaths in the United States linked to the blood thinner heparin, most of which occurred in December, January and February. According to an article in the New York Times, investigations continue into whether the deaths were caused by the Chinese contaminant.
[...]Bryan A. Liang, MD, PhD, JD
Vice President Bryan A. Liang, Ph.D, M.D., J.D. Professor of Anesthesiology Director, San Diego Center for Patient Safety, University of California San Diego School of Medicine Professor Bryan A. Liang is Professor of Anesthesiology and Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine as well as Vice President, Partnership for Safe Medicines.…
[...]